Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1830707 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Inhibition of human ERG | B | 4.55 | pIC50 | 28000 | nM | IC50 | J Med Chem (2011) 54: 5070-5081 [PMID:21688779] |
mGlu1 receptor/Metabotropic glutamate receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3772] [GtoPdb: 289] [UniProtKB: Q13255] | ||||||||
ChEMBL | Negative allosteric modulation of mGlu1 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2011) 54: 5070-5081 [PMID:21688779] |
ChEMBL | Positive allosteric modulation of mGlu1 receptor assessed as potentiation of glutamate-induced calcium mobilization | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2011) 54: 5070-5081 [PMID:21688779] |
mGlu2 receptor/Metabotropic glutamate receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5137] [GtoPdb: 290] [UniProtKB: Q14416] | ||||||||
ChEMBL | Negative allosteric modulation of mGlu2 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2011) 54: 5070-5081 [PMID:21688779] |
ChEMBL | Positive allosteric modulation of mGlu2 receptor assessed as potentiation of glutamate-induced calcium mobilization | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2011) 54: 5070-5081 [PMID:21688779] |
mGlu3 receptor/Metabotropic glutamate receptor 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2888] [GtoPdb: 291] [UniProtKB: Q14832] | ||||||||
ChEMBL | Negative allosteric modulation of mGlu3 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2011) 54: 5070-5081 [PMID:21688779] |
ChEMBL | Positive allosteric modulation of mGlu3 receptor assessed as potentiation of glutamate-induced calcium mobilization | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2011) 54: 5070-5081 [PMID:21688779] |
mGlu4 receptor/Metabotropic glutamate receptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2736] [GtoPdb: 292] [UniProtKB: Q14833] | ||||||||
ChEMBL | Positive allosteric modulation of human mGlu4 receptor expressed in BHK cells assessed as potentiation of glutamate-induced calcium mobilization after 1 hr by FLIPR assay | F | 8.05 | pEC50 | 9 | nM | EC50 | J Med Chem (2011) 54: 5070-5081 [PMID:21688779] |
GtoPdb | - | - | 8.1 | pEC50 | 9 | nM | EC50 | J Med Chem (2011) 54: 5070-81 [PMID:21688779] |
mGlu5 receptor/Metabotropic glutamate receptor 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3227] [GtoPdb: 293] [UniProtKB: P41594] | ||||||||
ChEMBL | Negative allosteric modulation of mGlu5 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2011) 54: 5070-5081 [PMID:21688779] |
ChEMBL | Positive allosteric modulation of mGlu5 receptor assessed as potentiation of glutamate-induced calcium mobilization | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2011) 54: 5070-5081 [PMID:21688779] |
mGlu7 receptor/Metabotropic glutamate receptor 7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3777] [GtoPdb: 295] [UniProtKB: Q14831] | ||||||||
ChEMBL | Negative allosteric modulation of mGlu7 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2011) 54: 5070-5081 [PMID:21688779] |
ChEMBL | Positive allosteric modulation of mGlu7 receptor assessed as potentiation of glutamate-induced calcium mobilization | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2011) 54: 5070-5081 [PMID:21688779] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]